Latest Anastrozole Stories
Big joy for soy! New research finds that high amounts of the wholesome combination of protein, isoflavones and fiber that make up soy lower the risk of cancer recurrence in post-menopausal breast cancer patients with hormone-sensitive cancers.
ANN ARBOR, Mich., Sept.
COLUMBUS, Ohio, July 8 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Anastrozole Tablets, 1mg by the U.S. Food and Drug Administration.
WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX.
PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S.
BOCA RATON, Fla., June 28 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that they will launch Anastrozole 1mg Tablets. The U.S.
Women's responsiveness to the second-line breast cancer drug fulvestrant may depend on whether the cancer cells are expressing two key proteins, Indiana University Bloomington scientists report in this month's Cancer Biology & Therapy.
REDWOOD CITY, Calif., March 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
WILMINGTON, Del., Dec.
Even when informed about risks, benefits, only 6% would take drug.
- A trick or prank.